Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
Clinical trials sponsored by Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- 3D-Printed eye patch could save sight without a donor Results expected Oct 2026 (estimated)
- New hope for breast cancer survivors: radiofrequency may ease menopause symptoms without hormones Results expected Dec 2026 (estimated)
- Can a wearable device keep heart failure patients out of the hospital? Results expected Jun 2027 (estimated)
-
Immunonutrition before surgery may cut complications and preserve muscle in colorectal cancer patients
Disease control CompletedThis trial compares two types of oral nutritional supplements given to colorectal cancer patients before surgery. One group receives standard high-protein drinks, while the other gets immunonutrition drinks enriched with arginine, nucleotides, vitamin D, and omega-3 fatty acids. …
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Poop pills could stop recurrent UTIs without antibiotics
Disease control CompletedThis completed Phase 2 trial tested fecal microbiota transfer (FMT) – a freeze-dried product made from healthy donor stool – in 40 women with recurrent urinary tract infections (UTIs). The goal was to see if FMT could prevent future UTIs by restoring healthy gut bacteria. Researc…
Phase 2 • Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC